Pfizer CEO: Why U.S. Pharma Needs China
Update: 2025-10-15
Description
Pfizer CEO urges U.S. drug companies to collaborate with China, citing China's explosive growth in pharmaceutical development. Discover why China now handles 30% of global drug development and how their speed and scale are reshaping the industry, despite U.S. lawmakers' concerns and trade tensions. Learn about Pfizer's massive deal with a Chinese firm and the increasing reliance on China for pharmaceutical innovation.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
